The medium-sized drugmaker Unichem Labs is exploring the sale of its Indian formulations business. The proposal, which is at a preliminary stage, is being studied by large strategic investors and private equity firms. Potential suitors could include big drugmakers like Mylan, Abbott, Sanofi, Teva and Pfizer. Investment bank Jefferies has been appointed to look for potential suitors. The valuation of Unichem is expected to be $1- 1.2 billion.
Copyright (c) 2015 . Informatics India Ltd., source Indian Business Insight